Let's Talk ID

From academia to industry: “It’s not a one-way valve.” In this episode with host Paul Sax, MD, FIDSA, infectious diseases physician Steven LaRosa, MD shares his journey to industry-sponsored research and its value as an ID career path. 

IDSA President Carlos del Rio, MD, FIDSA discusses what we can expect for the upcoming respiratory virus season with Meghan Pennini, PhD, the Chief Vaccines and Therapeutics Officer for H-CORE (the HHS Coordination Operations and Response Element) and the Office of the Assistant Secretary for Preparedness and Response (ASPR) at HHS.

The number of foreign medical graduates interested in infectious diseases is increasing. IDSA President Carlos del Rio, MD, FIDSA speaks to fellow Hispanic board members Lilian Abbo, MD, FIDSA, Cesar Arias, MD, MS, PhD, FIDSA and Max Brito, MD, MPH, FIDSA about their journeys to ID as foreign medical graduates and how to foster the next generation of Hispanic ID leaders. 

Forging a career in infectious diseases public health can be an isolating experience. In this episode, Mati Hlatshwayo Davis, MD, MPH, speaks with Virginia Caine, MD, Nahid Bhadelia, MD, MALD and Eric Chow, MD, MS, MPH, about their journeys in public health, including the importance of building accessible career paths for ID fellows. 

IDSA President Carlos del Rio MD, FIDSA sits down with CNN Chief Medical Correspondent Sanjay Gupta, MD to discuss lessons learned from the COVID-19 pandemic and how infectious diseases professionals can effectively communicate with decision makers and the public.

“Everything's negotiable in the locums world.” Locum tenens is a career path that is often discouraged for ID professionals. In this Let’s Talk ID episode with host Paul Sax, MD, FIDSA, locum tenens ID physician Allison Nazinitsky, MD shares how life in locum tenens provides better pay, work-life balance and a sense of appreciation. 

Twenty years ago, Buddy Creech, MD, MPH, FPIDS became a pediatric infectious diseases fellow under mega-mentor Kathryn Edwards, MD, FIDSA, FPIDS. In this episode, Dr. Creech is joined by his former mentor to discuss their story, the dynamics of a successful mentee and mentor relationship, and how to mentor trainees in the best way possible.

IDSA President Carlos del Rio MD, FIDSA, discusses the end of the COVID-19 public health emergency (PHE) with White House COVID-19 Response Coordinator Ashish Jha, MD, MPH. 

Buddy Creech, MD, MPH, FPIDS, sits down with guests William Schaffner, MD, FIDSA, and NBC News medical correspondent Erika Edwards to discuss how ID practitioners can be better communicators. 

The next time you take a careful travel history, think what it would be like to ask comedy writer Mike Reiss — he and his wife have been to more than a hundred countries, many of them far from the usual tourist routes. Paul Sax, MD, FIDSA, sits down with Reiss to discuss the good, the bad and the ugly. 

“If you have something to contribute, that contribution is going to be valued.” In 2019, Jasmine Marcelin, MD, FIDSA, became the youngest person to be elected to the IDSA Board of Directors. In this episode, Dr. Marcelin shares her journey, from experiencing “imposter syndrome,” balancing board work with a career and young children, and why age shouldn’t deter you from applying. 

Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines.

*This episode was recorded before the Paxlovid EPIC-SR results were released in an FDA briefing.

IDSA President-Elect Steven K. Schmitt, MD, FIDSA and IDSA Immediate Past President Daniel P. McQuillen, MD, FIDSA discuss their experience as clinicians serving on the IDSA Board of Directors.